Abstract
In the present study, we evaluated the impact of inframalleolar disease (IM) on major adverse limb events (MALE) in patients undergoing endovascular revascularization for chronic limb-threatening ischemia (CLTI).
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have